2019 | HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. | Ogawa, E; Toyoda, H; Iio, E; Jun, DW; Huang, CF; Enomoto, M; Hsu, YC; Haga, H; Iwane, S; Wong, G; Lee, DH; Tada, T; Liu, CH; Chuang, WL; Hayashi, J; Cheung, R; Yasuda, S; Tseng, CH; Takahashi, H; Tran, S; Yeo, YH; Henry, L; Barnett, SD; Nomura, H; Nakamuta, M; Dai, CY; Huang, JF; Yang, HI ; Lee, MH; Jung Jun, M; Kao, JH; Eguchi, Y; Ueno, Y; Tamori, A; Furusyo, N; Yu, ML; Tanaka, Y; Nguyen, MH; Ahn, SB; Azuma, K; Dohmen, K; Yoon Jeong, J; Jung, JH; Kajiwara, E; Kato, M; Kawano, A; Koyanagi, T; Ooho, A; Park, SH; Satoh, T; Shimoda, S; Song, DS; Takahashi, K; Yeh, ML; Yoon, EL | Clinical Infectious Diseases, ciz1160 | | | |
2013 | (The Year of Glycosciences) The Third ACGG-DB Meeting Report: Towards an international collaborative infrastructure for glycobioinformatics | Aoki-Kinoshita, KF; Sawaki, H; An, HJ; Cho, JW; Hsu, D; Kato, M; Kawano, S; Kawasaki, T; Khoo, KH ; Kim, J; Kim, JD; Li, X; Lutteke, T; Okuda, S; Packer, NH; Paulson, JC; Raman, R; Ranzinger, R; Shen, H; Shikanai, T; Yamada, I; Yang, P; Yamaguchi, Y; Ying, W; Yoo, JS; Zhang, Y; Narimatsu, H | Glycobiology 23(2), 144-146 | | | |